×
Huma Raises $80M To Accelerate Development of Digital Health Apps
Written by
Published on
Join our daily newsletter for breaking news, product launches and deals, research breakdowns, and other industry-leading AI coverage
Join Now

Huma, a London-based health-tech company, has launched an AI-powered cloud platform that enables startups to quickly prototype, launch, and scale regulated digital health apps, including those enhanced with AI capabilities.

Generative AI builder experience drives rapid app development: The Huma Cloud Platform offers a suite of tools, most notably a generative AI-powered builder that can transform text prompts into functional applications within minutes:

  • Users can create custom digital health apps using a combination of widgets, modules, templates, and disease management tools through a simple drag-and-drop interface.
  • If drag-and-drop functionality isn’t sufficient, users can leverage the generative AI builder by inputting a text prompt, which the platform’s algorithms use to intelligently assemble the necessary modules and elements.
  • The platform is built on Huma’s regulated and configurable technology, ensuring that apps developed on the platform are cleared for use in medical settings.

Expanding access and capabilities through funding: Huma has raised $80 million in Series D funding to further expand the reach of the platform and enhance its capabilities:

  • The Huma Cloud Platform is currently accessible to a select group of startups and pharmaceutical companies, with plans to expand beta access in the coming months.
  • A portion of the new funding will be allocated to the expansion of Huma Cloud, while the remainder will be used to add more capabilities to the platform through acquisitions and investments in the digital health space.
  • The latest round brings Huma’s total capital raised to over $300 million.

Huma’s track record and future goals: Over the past decade, Huma has developed a modular, configurable platform that has been used to create various healthcare apps, including those for remote patient monitoring, therapy/treatment, and decentralized clinical trials:

  • Huma’s platform has powered projects for more than 3,000 hospitals and clinics, as well as most of the top 20 pharmaceutical companies, engaging over 35 million individuals across 70 countries.
  • The company aims to accelerate the adoption of digital technologies and AI in healthcare, making these solutions affordable and accessible to all, ultimately transitioning medicine from reactive to proactive.

Broader implications: Huma’s AI-powered cloud platform has the potential to significantly impact the healthcare industry by lowering barriers to entry for startups and accelerating the development of innovative digital health solutions. However, the adoption of AI in healthcare has faced challenges due to concerns around trust and regulatory compliance. Huma’s platform, with its focus on the healthcare domain and regulatory approvals, aims to address these issues and facilitate the wider adoption of AI-powered solutions in medical settings. As more companies leverage the Huma Cloud Platform, it will be crucial to monitor its impact on patient outcomes, data privacy, and the overall transformation of healthcare delivery.

Huma raises $80M to turn text into healthcare apps with gen AI

Recent News

Nvidia’s new AI agents can search and summarize huge quantities of visual data

NVIDIA's new AI Blueprint combines computer vision and generative AI to enable efficient analysis of video and image content, with potential applications across industries and smart city initiatives.

How Boulder schools balance AI innovation with student data protection

Colorado school districts embrace AI in classrooms, focusing on ethical use and data privacy while preparing students for a tech-driven future.

Microsoft Copilot Vision nears launch — here’s what we know right now

Microsoft's new AI feature can analyze on-screen content, offering contextual assistance without the need for additional searches or explanations.